retatrutide effect on glucagon How Does Work? Triple Agonist Explained Retatrutide, a GIP, GLP-1 and

Manufactured by Eli Lilly, retatrutide is still in phase III clinical trials

Particularly popular for day trips and warm-weather holidays

Zepbound (Tirzepatide): Dual GLP-1 and GIP Activation Zepbound activates both GLP-1 receptors (like Wegovy) and adds GIP receptors into the equation

In addition to the GI tract and brain, as mentioned above, there are GLP-1 receptors in many other areas of the body, including the heart, lung and nervous system

Beyond balancing glucose levels by triggering insulin release [3] , GLP-1 touches on several areas that are top of mind for todays consumers, including weight management and overall wellbeing

Tirzepatide which targets both GLP-1 and GIP receptors has shown even more dramatic early results: weight loss of 1020 kg and insulin dose reductions exceeding 30% in observational and phase 2 data, with improved CGM time in range